Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
European Journal of Nuclear Medicine
|
April 13, 1999
Lessons for medicine and nuclear medicine research
E T Dams, F H Corstens
Lancet (London, England)
|
April 1, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies
E T Dams, J W van der Meer
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1995
Acute HELLP postpartum with renal failure
E T Dams, M H de Vleeschouwer, P W van Dongen
Journal of Internal Medicine
|
November 14, 1997
An unusual case of severe combined immunodeficiency with hypereosinophilia
E T Dams, F Mascart-Lemone, L Schandené, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 6, 2001
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation
O C Boerman, E T Dams, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 16, 2000
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes
P Laverman, S Zalipsky, W J Oyen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose
P Laverman, A H Brouwers, E T Dams, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection
P Laverman, M G Carstens, O C Boerman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Microscopic localization of PEG-liposomes in a rat model of focal infection
P Laverman, E T Dams, G Storm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 27, 1998
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study
E T Dams, W J Oyen, O C Boerman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
European Journal of Nuclear Medicine
|
April 13, 1999
Lessons for medicine and nuclear medicine research
E T Dams, F H Corstens
Lancet (London, England)
|
April 1, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies
E T Dams, J W van der Meer
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 1, 1995
Acute HELLP postpartum with renal failure
E T Dams, M H de Vleeschouwer, P W van Dongen
Journal of Internal Medicine
|
November 14, 1997
An unusual case of severe combined immunodeficiency with hypereosinophilia
E T Dams, F Mascart-Lemone, L Schandené, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 6, 2001
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation
O C Boerman, E T Dams, W J Oyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 16, 2000
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes
P Laverman, S Zalipsky, W J Oyen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2000
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose
P Laverman, A H Brouwers, E T Dams, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 17, 2001
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection
P Laverman, M G Carstens, O C Boerman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Microscopic localization of PEG-liposomes in a rat model of focal infection
P Laverman, E T Dams, G Storm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 27, 1998
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study
E T Dams, W J Oyen, O C Boerman, et al.
Page
of 2